Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BDH INDUS. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BDH INDUS.   TEVA PHARMA
EQUITY SHARE DATA
    BDH INDUS.
Mar-23
TEVA PHARMA
Dec-13
BDH INDUS./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2113,479-   
Low Rs933,022-   
Sales per share (Unadj.) Rs129.31,996.4-  
Earnings per share (Unadj.) Rs14.2124.7-  
Cash flow per share (Unadj.) Rs15.2286.1-  
Dividends per share (Unadj.) Rs4.00109.18-  
Avg Dividend yield %2.63.4 78.4%  
Book value per share (Unadj.) Rs95.02,217.6-  
Shares outstanding (eoy) m5.76848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.21.6 72.1%   
Avg P/E ratio x10.726.1 40.9%  
P/CF ratio (eoy) x10.011.4 87.7%  
Price / Book Value ratio x1.61.5 109.1%  
Dividend payout %28.187.5 32.1%   
Avg Mkt Cap Rs m8742,756,220 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m700-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m7451,692,969 0.0%  
Other income Rs m80-   
Total revenues Rs m7531,692,969 0.0%   
Gross profit Rs m110463,620 0.0%  
Depreciation Rs m6136,844 0.0%   
Interest Rs m233,253 0.0%   
Profit before tax Rs m111293,523 0.0%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m29-3,584 -0.8%   
Profit after tax Rs m82105,758 0.1%  
Gross profit margin %14.727.4 53.7%  
Effective tax rate %25.9-1.2 -2,118.6%   
Net profit margin %11.06.2 176.4%  
BALANCE SHEET DATA
Current assets Rs m6051,143,425 0.1%   
Current liabilities Rs m246997,163 0.0%   
Net working cap to sales %48.28.6 557.6%  
Current ratio x2.51.1 214.3%  
Inventory Days Days391 2.8%  
Debtors Days Days81696 850.6%  
Net fixed assets Rs m195552,961 0.0%   
Share capital Rs m584,167 1.4%   
"Free" reserves Rs m4890-   
Net worth Rs m5471,880,567 0.0%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m8003,868,976 0.0%  
Interest coverage x71.19.8 723.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 212.6%   
Return on assets %10.43.6 290.8%  
Return on equity %15.05.6 266.7%  
Return on capital %20.54.9 416.2%  
Exports to sales %51.70-   
Imports to sales %29.70-   
Net fx Rs m1630-   
CASH FLOW
From Operations Rs m63269,772 0.0%  
From Investments Rs m5-95,591 -0.0%  
From Financial Activity Rs m4-323,609 -0.0%  
Net Cashflow Rs m71-149,429 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare BDH INDUS. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare BDH INDUS. With: ALKEM LABORATORIES  SUVEN LIFE SCIENCES  PLETHICO PHARMA  VIVIMED LABS  BHARAT PARENTALS  



Today's Market

Gift Nifty Up 25 Points | Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today Gift Nifty Up 25 Points | Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.